Structures by: Bouissane L.
Total: 16
Ethyl (<i>E</i>)-2-(2,7-dimethyl-5-oxo-4<i>H</i>,5<i>H</i>-pyrano[4,3-<i>b</i>]pyran-4-ylidene)acetate
C14H14O5
IUCrData (2017) 2, 2 x170208
a=9.5679(12)Å b=11.4330(13)Å c=12.7993(15)Å
α=90° β=108.257(4)° γ=90°
4-Methoxy-<i>N</i>-(1-methyl-1<i>H</i>-indazol-7-yl)benzenesulfonamide hemihydrate
C15H15N3O3S,0.5(H2O)
IUCrData (2017) 2, 5 x170645
a=8.3013(5)Å b=13.1934(8)Å c=15.3583(9)Å
α=103.241(3)° β=105.470(3)° γ=93.046(3)°
C10H8N4O2
C10H8N4O2
New Journal of Chemistry (2019) 43, 36 14355
a=7.0748(4)Å b=8.1131(4)Å c=16.9559(9)Å
α=90° β=90° γ=90°
C10H8N4O2
C10H8N4O2
New Journal of Chemistry (2019) 43, 36 14355
a=6.5388(7)Å b=18.888(2)Å c=15.6064(18)Å
α=90° β=90° γ=90°
C10H8N4O2
C10H8N4O2
New Journal of Chemistry (2019) 43, 36 14355
a=9.2170(17)Å b=16.827(3)Å c=6.6121(13)Å
α=90° β=109.778(4)° γ=90°
C10H8N4O2
C10H8N4O2
New Journal of Chemistry (2019) 43, 36 14355
a=9.5041(12)Å b=10.9669(14)Å c=9.1780(12)Å
α=90° β=94.857(3)° γ=90°
C10H8N4O2
C10H8N4O2
New Journal of Chemistry (2019) 43, 36 14355
a=7.6034(4)Å b=14.7108(7)Å c=8.7184(4)Å
α=90° β=100.023(2)° γ=90°
C13H14N2O2
C13H14N2O2
New Journal of Chemistry (2009) 33, 1 125
a=13.2563(15)Å b=7.6962(9)Å c=22.855(3)Å
α=90.00° β=90.00° γ=90.00°
C21H20N2O4
C21H20N2O4
New Journal of Chemistry (2009) 33, 1 125
a=8.2394(10)Å b=14.0198(17)Å c=16.306(2)Å
α=90.00° β=101.060(3)° γ=90.00°
C20H20N2O2
C20H20N2O2
New Journal of Chemistry (2009) 33, 1 125
a=13.2363(13)Å b=8.2769(8)Å c=30.673(3)Å
α=90.00° β=90.00° γ=90.00°
C14H16N2O2
C14H16N2O2
New Journal of Chemistry (2009) 33, 1 125
a=8.519(2)Å b=12.964(4)Å c=34.615(10)Å
α=90.00° β=94.607(7)° γ=90.00°
<i>N</i>-(2-Allyl-4-ethoxy-2<i>H</i>-indazol-5-yl)-4-methylbenzenesulfonamide
C19H21N3O3S
Acta Crystallographica Section E (2014) 70, 5 o624
a=26.0808(5)Å b=7.9335(2)Å c=21.1573(4)Å
α=90.00° β=122.8390(10)° γ=90.00°
<i>N</i>-(1-Allyl-3-chloro-4-ethoxy-1<i>H</i>-indazol-5-yl)-4-methylbenzenesulfonamide
C19H20ClN3O3S
Acta Crystallographica Section E (2014) 70, 6 o653
a=10.0345(2)Å b=10.5208(2)Å c=10.7237(2)Å
α=71.5610(10)° β=69.6010(10)° γ=83.0390(10)°
<i>N</i>-(3-Chloro-1<i>H</i>-indazol-5-yl)-4-methoxybenzenesulfonamide
C14H12ClN3O3S
Acta Crystallographica Section E (2013) 69, 11 o1632
a=16.1229(5)Å b=10.0562(3)Å c=9.7955(2)Å
α=90.00° β=105.3880(10)° γ=90.00°
<i>N</i>-(1<i>H</i>-Indazol-5-yl)-4-methoxybenzenesulfonamide
C14H13N3O3S
Acta Crystallographica Section E (2013) 69, 11 o1702
a=8.9996(4)Å b=7.1999(3)Å c=21.3728(10)Å
α=90.00° β=91.794(3)° γ=90.00°
<i>N</i>-(1-Allyl-3-chloro-4-ethoxy-1<i>H</i>-indazol-5-yl)-4-\ methoxybenzenesulfonamide
C19H20ClN3O4S
Acta Crystallographica Section E (2014) 70, 9 o1029-o1030
a=8.2699(7)Å b=13.1235(12)Å c=10.0026(9)Å
α=90.00° β=110.379(5)° γ=90.00°